These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 22270043)

  • 1. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ; Kholod N; van Leeuwen FW
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
    Paul S
    Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
    Ardley HC; Hung CC; Robinson PA
    FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
    van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
    Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescent reporters for the ubiquitin-proteasome system.
    Salomons FA; Verhoef LG; Dantuma NP
    Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation and ubiquitination in neurodegeneration.
    Riederer BM; Leuba G; Elhajj Z
    Exp Biol Med (Maywood); 2013 May; 238(5):519-24. PubMed ID: 23856903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders.
    Iacovelli L; Fulceri F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
    Exp Neurol; 2006 Sep; 201(1):24-31. PubMed ID: 16678160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
    von Mikecz A; Chen M; Rockel T; Scharf A
    Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.
    de Vrij FM; Fischer DF; van Leeuwen FW; Hol EM
    Prog Neurobiol; 2004 Dec; 74(5):249-70. PubMed ID: 15582222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction.
    Tai HC; Schuman EM
    Nat Rev Neurosci; 2008 Nov; 9(11):826-38. PubMed ID: 18931696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the ubiquitin proteasome system in Alzheimer's disease.
    Riederer BM; Leuba G; Vernay A; Riederer IM
    Exp Biol Med (Maywood); 2011 Mar; 236(3):268-76. PubMed ID: 21383047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
    Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
    Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.
    Deger JM; Gerson JE; Kayed R
    Aging Cell; 2015 Oct; 14(5):715-24. PubMed ID: 26053162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology].
    Shelkovnikova TA; Kulikova AA; Tsvetkov FO; Peters O; Bachurin SO; Bukhman VL; Ninkina NN
    Mol Biol (Mosk); 2012; 46(3):402-15. PubMed ID: 22888630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of autophagy in age-related neurodegeneration.
    McCray BA; Taylor JP
    Neurosignals; 2008; 16(1):75-84. PubMed ID: 18097162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
    Schmitt HP
    Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.